264 related articles for article (PubMed ID: 20152899)
21. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
22. [Research from the Palliative Care Department in Poznań on treatment of neoplasm pain with Durogesic (transdermal fentanyl)].
Leppert W; Luczak J; Gorzelińska L; Kozikowska J
Przegl Lek; 2000; 57(1):59-64. PubMed ID: 10907375
[TBL] [Abstract][Full Text] [Related]
23. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of fentanyl delivered transdermally in healthy adult horses--variability among horses and its clinical implications.
Orsini JA; Moate PJ; Kuersten K; Soma LR; Boston RC
J Vet Pharmacol Ther; 2006 Dec; 29(6):539-46. PubMed ID: 17083458
[TBL] [Abstract][Full Text] [Related]
25. Transdermal matrix fentanyl membrane patch (matrifen): in severe cancer-related chronic pain.
Hair PI; Keating GM; McKeage K
Drugs; 2008; 68(14):2001-9. PubMed ID: 18778121
[TBL] [Abstract][Full Text] [Related]
26. LC-MS/MS analysis of fentanyl and norfentanyl in a fatality due to application of multiple Durogesic transdermal therapeutic systems.
Coopman V; Cordonnier J; Pien K; Van Varenbergh D
Forensic Sci Int; 2007 Jul; 169(2-3):223-7. PubMed ID: 16650707
[TBL] [Abstract][Full Text] [Related]
27. A Phase III study to assess the clinical utility of low-dose fentanyl transdermal system in patients with chronic nonmalignant pain.
Otis J; Rothman M
Curr Med Res Opin; 2006 Aug; 22(8):1493-501. PubMed ID: 16870074
[TBL] [Abstract][Full Text] [Related]
28. Regional differences in transdermal penetration of fentanyl through equine skin.
Mills PC; Cross SE
Res Vet Sci; 2007 Apr; 82(2):252-6. PubMed ID: 17011603
[TBL] [Abstract][Full Text] [Related]
29. Plasma profiles of transdermal 17 beta-estradiol delivered by two different matrix patches. A four-way cross-over study in postmenopausal women.
Rohr UD; Ehrly AM; Kuhl H
Arzneimittelforschung; 1997 Jun; 47(6):761-7. PubMed ID: 9239456
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the single- and multiple-dose pharmacokinetics of fentanyl buccal soluble film in normal healthy volunteers.
Vasisht N; Gever LN; Tagarro I; Finn AL
J Clin Pharmacol; 2010 Jul; 50(7):785-91. PubMed ID: 20150521
[TBL] [Abstract][Full Text] [Related]
31. Differential sensitivity of three experimental pain models in detecting the analgesic effects of transdermal fentanyl and buprenorphine.
Koltzenburg M; Pokorny R; Gasser UE; Richarz U
Pain; 2006 Dec; 126(1-3):165-74. PubMed ID: 16901645
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of efficacy and safety of fentanyl transdermal patch (Durogesic D-TRANS) in chronic pain.
Park JH; Kim JH; Yun SC; Roh SW; Rhim SC; Kim CJ; Jeon SR
Acta Neurochir (Wien); 2011 Jan; 153(1):181-90. PubMed ID: 20821238
[TBL] [Abstract][Full Text] [Related]
33. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
[TBL] [Abstract][Full Text] [Related]
35. Bioequivalence and safety of a novel fentanyl transdermal matrix system compared with a transdermal reservoir system.
Moore KT; Adams HD; Natarajan J; Ariyawansa J; Richards HM
J Opioid Manag; 2011; 7(2):99-107. PubMed ID: 21561033
[TBL] [Abstract][Full Text] [Related]
36. Disposition of transdermally administered fentanyl in dogs.
Kyles AE; Papich M; Hardie EM
Am J Vet Res; 1996 May; 57(5):715-9. PubMed ID: 8723888
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of a new fentanyl tape with a novel delivery system of transdermal matrix patches in patients with cancer pain.
Saito T; Fujii M; Saito S; Shimada K; Fujiwara K; Kobayashi K
Oncology; 2014; 86(1):10-5. PubMed ID: 24335580
[TBL] [Abstract][Full Text] [Related]
38. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.
Kim SD; Kang W; Lee HW; Park DJ; Ahn JH; Kim MJ; Kim EY; Kim SW; Nam HS; Na HJ; Yoon YR
Clin Ther; 2009 Apr; 31(4):793-803. PubMed ID: 19446152
[TBL] [Abstract][Full Text] [Related]
39. Effect of local administration of transdermal fentanyl on peripheral opioid analgesia.
Worrich S; Schuler G; Janicki PK
Pain Med; 2007; 8(1):41-7. PubMed ID: 17244103
[TBL] [Abstract][Full Text] [Related]
40. Transdermal fentanyl system plus im ketorolac for the treatment of postoperative pain.
Reinhart DJ; Goldberg ME; Roth JV; Dua R; Nevo I; Klein KW; Torjman M; Vekeman D
Can J Anaesth; 1997 Apr; 44(4):377-84. PubMed ID: 9104519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
